Dr. Amengual outlines how patients with relapsed lymphoma can approach clinical trials, including phases, eligibility and key questions to ask providers.
Dr. Jennifer Amengual
Advertisement
A lymphoma specialist at Columbia University.
Articles by Dr. Jennifer Amengual
Dr. Jennifer Amengual explains how epigenetic therapies treat lymphomas by changing gene expression rather than killing dividing cells like chemotherapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
3
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
4
If I Have Cancer Again
5